Kobe, Japan

Yoshihisa Shirasaki

This inventor holds 1 USPTO granted patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihisa Shirasaki. Retrieved from https://idiyas.com/inventor/yoshihisa-shirasaki-ol6caap2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshihisa Shirasaki: Innovator in Alpha-Ketoamide Derivatives

Introduction

Yoshihisa Shirasaki is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on alpha-ketoamide derivatives. His research and inventions have the potential to impact various applications in medicine.

Latest Patents

Yoshihisa Shirasaki holds a patent for an alpha-ketoamide derivative, along with its production method and uses. This invention is represented by a specific chemical formula, which showcases his expertise in the development of novel compounds. The patent highlights the importance of his work in advancing pharmaceutical science.

Career Highlights

Shirasaki is associated with Senju Pharmaceutical Co., Ltd., where he has been able to apply his knowledge and skills in a professional setting. His career reflects a commitment to innovation and the pursuit of new solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Yoshihisa Shirasaki has collaborated with esteemed colleagues, including Jun Inoue and Hiroyuki Miyashita. These partnerships have likely contributed to the success of his projects and the advancement of their shared goals in research and development.

Conclusion

Yoshihisa Shirasaki is a prominent figure in the field of pharmaceutical innovation, with a focus on alpha-ketoamide derivatives. His contributions through patents and collaborations underscore his role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…